Actively Recruiting
Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study
Led by University of Alberta · Updated on 2026-01-08
60
Participants Needed
1
Research Sites
128 weeks
Total Duration
On this page
Sponsors
U
University of Alberta
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The chemotherapy medications used for breast cancer treatment are important for achieving a cure, but a potential side effect is that they can cause a decline in functional capacity (reduced exercise tolerance and impaired physical function) and increase the risk of cardiovascular disease. The risks of decreased functional capacity and cardiovascular disease are highest in breast cancer survivors as they grow older. The factors causing the decline in functional capacity are not well understood, however they may be related to a reduction in cardiac function (e.g. decreased pumping ability of the heart) or skeletal muscle function (reduced muscle blood flow and oxygenation). Exercise training is used for other populations at risk for cardiovascular disease (such as cardiac rehabilitation), but is not routinely offered to breast cancer survivors. Therefore this research study wants to test whether exercise training can improve heart and muscle health, and increase functional capacity in up to 60 older breast cancer survivors aged \>60 years old who previously received chemotherapy drugs that can affect the heart. The purpose of this study is to compare two rehabilitation approaches: a 12-week structured exercise training program or a 12-week stretching-yoga program. The investigators want to compare whether these programs can improve functional capacity, and heart and skeletal muscle function. To do this, some of the participants in this study will be randomly enrolled in the structured exercise training program and others will be randomly enrolled in the stretching-yoga program.
CONDITIONS
Official Title
Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years
- Previously diagnosed with early-stage (I-III) breast cancer
- Completed at least 1 year post primary cardiotoxic treatment (anthracycline-based chemotherapy or trastuzumab-based biological therapy)
You will not qualify if you...
- History of coronary artery disease, heart failure, persistent or permanent arrhythmia (e.g., atrial fibrillation), stroke, or chronic obstructive pulmonary disease
- Signs or symptoms of myocardial ischemia during cardiopulmonary test
- Any MRI contraindications or orthopedic limitations preventing exercise testing
- Currently performing structured exercise training (30 minutes/day, 4 or more days/week)
- Unwillingness to be randomized to either exercise training or stretching program
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Alberta
Edmonton, Alberta, Canada, T6G1C9
Actively Recruiting
Research Team
N
Nathan Weeldreyer, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here